Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
Clinical trial NCT01016093 · UNKNOWN
Trial details
- NCT number
- NCT01016093
- Sponsor
- Tehran University of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.